Nathealthsolutions LLC is the exclusive worldwide distributor of BergaMet Products based on the Patented Bergamot Polyphenolic Fraction (BPF) extract. H & AD srl is a company that holds a long-term contract with the consortium of Bergamot fruit growers in the Reggio Calabria region. H&AD is the sole world supplier of the patented, finished extract BPF and is presently building a new manufacturing facility that will produce the highest quality extract yet available to the global market.
Selwyn Barr, CEO of Nathealthsolutions, stated, "I am excited about the future of this new agreement as it will control all facets of the product from the grower to the end user worldwide. I firmly believe that the Bergamot Polyphenolic Fraction extract will, in the not too distant future, be recognized as one of the most significant natural product discoveries in the last several decades."
All intellectual property owned by both companies, including trademarks, patents and clinical research information will be immediately transferred to the new JV under this Agreement, thus offering optimal protection to all customers and partners of both companies and individuals in the future. Both parties stressed their commitment to vigorously enforce the intellectual property against all companies or individuals who infringe or make false claims regarding any aspect of the intellectual property.
There is only one genuine patented extract, which Bergamot Polyphenolic Fraction or BPF. It is this extract and only this extract that has been used in every one of the clinical trials to date. Further, BergaMet is the only finished product that has faithfully followed the same formulations used in the trials. BergaMet products are the only ones endorsed by all of the researchers who have studied the extract, and they are approved by the Accademia of Bergamotto the historical Bergamot Consortium of Reggio Calabria, Italy. BergaMet products in all of its dietary supplement forms is the only product that is studied, used and recommended by many of the world's leading cardiologists and physicians.
"I firmly believe that there is no other natural product that have been given such significant endorsements," said Mr. Barr. "The surface has only been scratched on the enormous potential health impact of this unique Mediterranean fruit extract and I believe that we will continued to discover more and more benefits providing clinically significant options that can improve the health of people throughout the world."
The new JV Agreement will enable the continuation of an aggressive program of scientific studies, especially in the field of liver health.